- Home
- HBIO vs VRCA Comparison
HBIO vs VRCA Comparison
Compare HBIO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HBIO | VRCA |
|---|---|---|
| Founded | 1901 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8M | 32.7M |
| IPO Year | 2000 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HBIO | VRCA |
|---|---|---|
| Price | $0.71 | $8.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 402.7K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,371,000.00 | $30,829,000.00 |
| Revenue This Year | N/A | $373.65 |
| Revenue Next Year | $7.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 234.73 |
| 52 Week Low | $0.28 | $3.28 |
| 52 Week High | $2.36 | $9.82 |
Technical Indicators
Market Signals| Indicator | HBIO | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 54.13 | 63.97 |
| Support Level | $0.71 | $7.82 |
| Resistance Level | $0.78 | $9.78 |
| Average True Range (ATR) | 0.07 | 1.17 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 37.24 | 67.76 |
Price Performance
Historical ComparisonAbout HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.